Saccharomyces Cerevisiae for Irritable Bowel Syndrome
Pakistan30 participantsStarted 2021-03-01
Plain-language summary
This study is designed to see the response of saccharomyces cerevisiae for symptomatic improvement of patients with IBS
Who can participate
Age range18 Years – 75 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Male and female patients between 18 and 75 years of age,
* Patients having confirmed IBS according to Rome IV criteria (newly and previously non-responder to treatment),
* Pain/ discomfort score strictly above 1 and strictly below 6 as determined on a pain/ discomfort scale using arbitrary grading from 0 to 7 in 7 days preceding the inclusion visit,
* Not hypersensitive to any of the ingredients of the drug.
Exclusion Criteria:
* Patients with an organic intestinal disease (Crohn's disease, ulcerative colitis, etc.),
* Pregnant females
* Treatments likely to influence IBS (anti-depressants, opioids, and narcotic analgesics)
* Patients with chronic alcoholism, vegetarian or vegan regimens
* Eating disorders such as anorexia or bulimia
* Documented food allergies.
What they're measuring
1
To determine the response of saccharomyces cerevisiae for symptomatic improvement in patients with Irritablebowel syndrome through pain/ discomfort score